Recombinant VEGF (Bevacizumab Biosimilar) antibody
Reactivity: Human
FACS, ELISA, BR, IP, WB
Host: Human
Monoclonal
unconjugated
Recombinant Antibody
-
- Target See all VEGF (Bevacizumab Biosimilar) products
- VEGF (Bevacizumab Biosimilar)
- Antibody Type
- Recombinant Antibody
- Reactivity
- Human
-
Host
-
Human
-
Clonality
- Monoclonal
-
Conjugate
- This VEGF (Bevacizumab Biosimilar) antibody is un-conjugated
-
Application
- Flow Cytometry (FACS), ELISA, Blocking Reagent (BR), Immunoprecipitation (IP), Western Blotting (WB)
- Specificity
- This antibody binds native and reduced human VEGF (isoform 165).
- Characteristics
-
OriginalSpeciesName: Human
OriginalFormat: IgG1
- Purification
- Purified antibody.
- Purity
- > 98 % as determined by SDS-PAGE
- Endotoxin Level
- Endotoxin is < 1.0 EU/mg as determined by the LAL method
- Immunogen
- Recombinant human VEGF.
- Isotype
- IgG1 kappa
-
-
- Application Notes
- This is a research-grade biosimilar against VEGF. VEGF is a growth factor active in angiogenesis, vasculogenesis and endothelial cell growth. It induces endothelial cell proliferation, promotes cell migration, inhibits apoptosis and induces permeabilization of blood vessels.
- Comment
-
NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar.
- Restrictions
- For Research Use only
-
- Buffer
- PBS with 0.02 % Proclin 300.
- Preservative
- ProClin
- Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Storage
- 4 °C,-20 °C
- Storage Comment
- Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.
-
- Target
- VEGF (Bevacizumab Biosimilar)
- Abstract
- VEGF (Bevacizumab Biosimilar) Products
- Synonyms
- MVCD1 antibody, VEGF antibody, VPF antibody, vascular endothelial growth factor A antibody, VEGFA antibody
- Background
- Ascular Endothelial Growth Factor, VEGF-A, VEGFA, Vascular Permeability Factor, VPF
- UniProt
- P15692
-
You are here:
